- Medical Device
- Cetus merges into Chiron creating major force in biotech.
- Bayer AG acquires Chiron Diagnostics for $1.1bn in cash
- Abbott licenses Chiron's HCV patents
- Chiron and Gen-Probe ally to develop blood screening products
- Chiron & Genelabs in $24 million hepatitis diagnostics pact
- Ciba-Geigy AG to hold 49.9% of Chiron
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. email@example.com.
All fields are required.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.